Dr. Reddy’s Loses More Than Half Of Yearly Gains After U.S. Court Order
General views of drugs (Photographer: Brent Lewin/Bloomberg)

Dr. Reddy’s Loses More Than Half Of Yearly Gains After U.S. Court Order

Dr. Reddy’s Laboratories Ltd. wiped off more than half of its yearly gains after a U.S. appeals court temporarily prevented it from selling a generic version of Indivior Plc’s Suboxone opioid addic...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.